Eam Investors, LLC Novo Cure LTD Transaction History

Eam Investors, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 13, 2020	SELL	$57.05 - $95.75 $1.11 Million - $1.87 Million	-19,534 Closed	0 $0
Q4 2019 Feb 11, 2020	SELL	$68.3 - $93.8 $178,877 - $245,662	-2,619 Reduced 11.82%	19,534 $1.65 Million
Q3 2019 Nov 13, 2019	SELL	$61.86 - $97.8 $166,465 - $263,179	-2,691 Reduced 10.83%	22,153 $1.66 Million
Q2 2019 Aug 14, 2019	SELL	$42.22 - $63.23 $94,868 - $142,077	-2,247 Reduced 8.29%	24,844 $1.57 Million
Q1 2019 May 13, 2019	BUY	$31.96 - $56.12 $865,828 - $1.52 Million	27,091 New	27,091 $1.31 Million
Q4 2018 Feb 13, 2019	SELL	$28.72 - $52.63 $2.2 Million - $4.03 Million	-76,573 Closed	0 $0
Q3 2018 Nov 08, 2018	SELL	$32.0 - $52.4 $806,400 - $1.32 Million	-25,200 Reduced 24.76%	76,573 $4.01 Million
Q2 2018 Aug 03, 2018	BUY	$19.85 - $32.0 $2.02 Million - $3.26 Million	101,773 New	101,773 $3.19 Million
Q1 2018 May 14, 2018	SELL	$19.3 - $23.65 $2.27 Million - $2.78 Million	-117,668 Closed	0 $0
Q4 2017 Feb 12, 2018	BUY	$16.3 - $21.9 $1.92 Million - $2.58 Million	117,668	117,668 $2.38 Million

263

77M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $3.23B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Eam Investors, LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Investors, LLC with notifications on news.